JD-5037
JD-5037 is a potent and selective CB1 receptor antagonist with an IC50 of 1.5 nM, designed for peripheral restriction. It is a valuable research tool for investigating metabolic disorders, such as obesity and fatty liver disease, in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1392116-14-1
Product Name Alternative
Inhibitor, inhibit, JD5037, JD-5037, JD 5037, CannabinoidReceptor, Cannabinoid Receptor, CB1R, CB
Field of Research
Pharmacology & Drug Discovery
Purity
98.14% (May vary between batches)
Solubility
DMSO:240 mg/mL (419.21 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.49 mM)
Smiles
CC (C) [C@H] (\N=C (\NS (=O) (=O) c1ccc (Cl) cc1) N1C[C@@H] (C (=N1) c1ccc (Cl) cc1) c1ccccc1) C (N) =O
Molecular Formula
C27H27Cl2N5O3S
Molecular Weight
572.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV670040 1.0 µg DNA
KBTBD7 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details MBS6499919-01 0.2 mL
SMURF2, NT (E3 Ubiquitin-protein Ligase SMURF2, Smad Ubiquitination Regulatory Factor 2, Ubiquitin-protein Ligase SMURF2, Smad-specific E3 Ubiquitin Ligase 2, hSMURF2) (AP)
Sign In for Pricing
View Details MBS6499919-02 5x 0.2 mL
SMURF2, NT (E3 Ubiquitin-protein Ligase SMURF2, Smad Ubiquitination Regulatory Factor 2, Ubiquitin-protein Ligase SMURF2, Smad-specific E3 Ubiquitin Ligase 2, hSMURF2) (AP)
Sign In for Pricing
View Details